secwatch.observer — SEC 8-K summary
======================================

Issuer:     MANGOCEUTICALS, INC. (MGRX)
CIK:        0001938046
Form:       8-K
Filed at:   2025-05-30T23:59:59+00:00
Accession:  0001641172-25-012917
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mangoceuticals raises $116K in unit offering, converts $500K note into convertible debt
--------------------------------------------------------------------------------

- Issued 70,454 units at $1.65 each for $116,249, each unit includes 1 share and half warrant to buy 1 share at $3.00.
- Amended $500K promissory note with Indigo Capital LP into convertible note at $1.50/share, removing mandatory prepayment clause.
- Granted Indigo Capital warrants to purchase 275,482 shares at $1.815/share, expiring May 27, 2028.
- Issued 120,000 restricted shares to Levo Healthcare for digital marketing services, vesting 10,000 shares/month over 36 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1938046/000164117225012917/0001641172-25-012917-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1938046/000164117225012917/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-012917

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer